See the DrugPatentWatch profile for klonopin

Based on the information available, there is no specific data or recent reports indicating the exact change in Binomo Pharma's 1mg Klonopin market share. However, it is known that Binomo Pharma is one of the companies that manufacture Clonazepam, which is sold under the brand name Klonopin [1]. Clonazepam is a medication used to treat panic disorder, akathisia, or restless legs syndrome [1].

To understand the market share of Binomo Pharma's 1mg Klonopin, it would be helpful to look at the overall Clonazepam market. According to a report by Mordor Intelligence, the global clonazepam market was valued at USD 1.2 billion in 2020 and is expected to reach USD 1.6 billion by 2026, growing at a CAGR of 4.5% during the forecast period (2021-2026) [2]. However, this report does not provide a breakdown of the market share of individual companies or brands.

A search on DrugPatentWatch.com reveals that Binomo Pharma has an active patent for Clonazepam 0.5mg and 2mg tablets, which will expire in 2031 [3]. This suggests that Binomo Pharma has a significant presence in the Clonazepam market. However, it does not provide information on the company's market share for 1mg Klonopin.

In conclusion, while there is no specific data available on Binomo Pharma's 1mg Klonopin market share, the company has an active patent for Clonazepam and is expected to have a significant presence in the Clonazepam market. The global Clonazepam market is expected to grow at a CAGR of 4.5% during the forecast period (2021-2026) [2].

Sources:
[1] "Clonazepam (Klonopin)" by RxList, <https://www.rxlist.com/clonazepam_drug.htm>
[2] "Clonazepam Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" by Mordor Intelligence, <https://www.mordorintelligence.com/industry-reports/clonazepam-market>
[3] "Clonazepam" by DrugPatentWatch, <https://www.drugpatentwatch.com/drugs/clonazepam>